News Fired ACIP panel says RFK Jr is weakening vaccine programmes RFK Jr's interference in the ACIP is putting patients at risk, claim the 17 members of the panel abruptly fired last week.
News Moderna's RSV shot gets US nod for use in younger adults The label for Moderna's RSV vaccine mResvia has been expanded to include adults aged 18 and over in the US, but will that lead to an uptick in sales?
News Pushback rises against RFK Jr's new ACIP membership Medical groups have criticised Robert F Kennedy Jr's newly constituted CDC vaccine advisory panel, calling for the previous experts to be reinstated.
News MSD aims to plug dengue fever vaccine gap in US MSD is preparing to take on Takeda in the dengue fever vaccine market, moving its V181 candidate into phase 3.
News Concerns rise over ACIP's new membership RFK Jr names eight members of the CDC's vaccine panel, some known for contrarian views on immunisation, after ousting all 17 of their predecessors.
News Dismay as RFK Jr ousts CDC vaccine advisors RFK Jr has removed all 17 members of the CDC's vaccine advisory committee in a move that some fear could lead to restrictions on immunisation access.
R&D Precision, speed, impact: Evolving mass spectrometry for med... MOBILion's Melissa Sherman explores the evolving role of mass spectrometry in drug discovery, complex molecule analysis, and medical research.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
